Viewing Study NCT06090669


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:27 PM
Study NCT ID: NCT06090669
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-10-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module